Halozyme(HALO) - 2023 Q2 - Earnings Call Transcript

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q2 2023 Earnings Conference Call August 8, 2023 4:30 AM ET Company Participants Tram Bui - VP, IR and Corporate Communications Helen Torley - President and CEO Nicole LaBrosse - CFO Conference Call Participants Mohit Bansal - Wells Fargo Michael DiFiore - Evercore ISI David Risinger - Leerink Partners Jason Butler - JMP Securities Mitchell Kapoor - H.C. Wainwright Mack Chandler - Jefferies Caroline Palomeque - Berenberg Capital Markets Operator Good afternoon, my n ...